Literature DB >> 3627708

Heparin prophylaxis for intraocular fibrin.

R N Johnson, E Balyeat, W H Stern.   

Abstract

The authors have evaluated the use of heparin as a method to prevent postoperative intraocular fibrin clot formation in the rabbit after vitrectomy and cyclocryotherapy. In addition, they have studied the effect of a heparin infusion on intraocular bleeding after sectioning of retinal vessels. Heparin was administered by several different routes. The extent of the postoperative fibrin clot, as well as the number of days until its clearing, were recorded. A single anterior chamber injection, heparin supplementation of the infusion solution, or a single intravenous (IV) injection, all resulted in a statistically significant reduction of postoperative intraocular fibrin. Once daily subcutaneous injections alone did not produce a reduction in postoperative fibrin. No ocular bleeding complications developed postoperatively. A constant heparin intraocular infusion of 10 IU/cc did not change the bleeding time after sectioning of a retinal vessel.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3627708     DOI: 10.1016/s0161-6420(87)33403-7

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  7 in total

1.  Intravitreal recombinant tissue plasminogen activator in the treatment of experimentally induced bacterial endophthalmitis.

Authors:  N Baziuk; T Fang; G A Peyman; C M Gremillion
Journal:  Int Ophthalmol       Date:  1991-03       Impact factor: 2.031

2.  Effect of low molecular weight heparin (enoxaparin) on congenital cataract surgery.

Authors:  Ihsan Caça; Alparslan Sahin; Abdullah Kürsat Cingü; Seyhmus Ari; Fuat Alakuş; Yasin Cinar
Journal:  Int J Ophthalmol       Date:  2012-10-18       Impact factor: 1.779

3.  Transplantation of congenitally opaque corneas.

Authors:  B E Frueh; S I Brown
Journal:  Br J Ophthalmol       Date:  1997-12       Impact factor: 4.638

4.  Heparinised intraocular infusion and bacterial contamination in cataract surgery.

Authors:  T D Manners; D P Turner; P H Galloway; A M Glenn
Journal:  Br J Ophthalmol       Date:  1997-11       Impact factor: 4.638

5.  A prospective, open-label, dose-escalating study of low molecular weight heparin during repeat vitrectomy for PVR and severe diabetic retinopathy.

Authors:  R Gary Lane; J Michael Jumper; Ma'an A Nasir; Mathew W MacCumber; Brooks W McCuen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-03       Impact factor: 3.117

6.  Does the presence of heparin and dexamethasone in the vitrectomy infusate reduce reproliferation in proliferative vitreoretinopathy?

Authors:  R G Williams; S Chang; M R Comaratta; G Simoni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

7.  Inhibition of intraocular fibrin formation with annexin V.

Authors:  P Chollet; F Malecaze; F Hullin; P Raynal; J L Arne; V Pagot; J Ragab-Thomas; H Chap
Journal:  Br J Ophthalmol       Date:  1992-08       Impact factor: 4.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.